Author:
Olamide Omigbile,Adebayo Oni,Emmanuel Abe,Eyitayo Lawal,Beatrice Oyasope,Tomisin Mayaki
Abstract
This chapter gives an overview of the prevalence and risk factors of cardiovascular diseases (CVDs) among Nigerian population with emphasis on the younger population. The Nigerian population is largely dominated by youths who contribute significantly toward economic growth of the country. Addressing the issues of cardiovascular diseases among this population offers an opportunity toward increasing life expectancy and building a healthy nation. In order to understand the issues at hand, this chapter detailed the prevalence of cardiovascular diseases among youths, and it also identifies the risk factors that contribute to the development of CVDs among the population. Furthermore, it gave recommendations on how the issue of CVDs among the younger population can be addressed.
Reference106 articles.
1. World Health Organization. Cardiovascular Diseases (cvds). 2009. Available from: http://www. who. int/mediacentre/factsheets/fs317/en/index. html [Accessed: 12 August 2022]
2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study. Journal of the American College of Cardiology. 2020;76(25):2982-3021. DOI: 10.1016/j.jacc.2020.11.010
3. World Health Organization. Global Status Report on Non- communicable Diseases. Geneva, Switzerland: World Health Organization; 2010 Available from: https://www.who.int/health-topics/cardiovascular-diseases
4. Adegoke OA, Adedoyin RA, Balogun MO, Adebayo RA, Bisiriyu LA, Salawu AA. Prevalence of metabolic syndrome in a rural community in Nigeria. Metabolic Syndrome and Related Disorders. 2010;8(1):59-62. DOI: 10.1089/met.2009.0037
5. Mytton OT, Jackson C, Steinacher A, Goodman A, Langenberg C, Griffin S, et al. The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: a microsimulation study. PLoS Medicine. 6 Mar 2018;15(3):e1002517